ATE412750T1 - Antigen aus streptococcus pyogenes - Google Patents

Antigen aus streptococcus pyogenes

Info

Publication number
ATE412750T1
ATE412750T1 AT01951286T AT01951286T ATE412750T1 AT E412750 T1 ATE412750 T1 AT E412750T1 AT 01951286 T AT01951286 T AT 01951286T AT 01951286 T AT01951286 T AT 01951286T AT E412750 T1 ATE412750 T1 AT E412750T1
Authority
AT
Austria
Prior art keywords
antigen
streptococcus pyogenes
streptococcus
prophylaxis
antigens
Prior art date
Application number
AT01951286T
Other languages
German (de)
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard Brodeur
Stephane Rioux
Martine Boyer
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE412750T1 publication Critical patent/ATE412750T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01951286T 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes ATE412750T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06

Publications (1)

Publication Number Publication Date
ATE412750T1 true ATE412750T1 (de) 2008-11-15

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951286T ATE412750T1 (de) 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (cg-RX-API-DMAC7.html)
EP (1) EP1297145B1 (cg-RX-API-DMAC7.html)
JP (1) JP4718099B2 (cg-RX-API-DMAC7.html)
AT (1) ATE412750T1 (cg-RX-API-DMAC7.html)
AU (1) AU7227001A (cg-RX-API-DMAC7.html)
BR (1) BR0112497A (cg-RX-API-DMAC7.html)
CA (1) CA2413576C (cg-RX-API-DMAC7.html)
DE (1) DE60136360D1 (cg-RX-API-DMAC7.html)
ES (1) ES2316458T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002004495A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4718099B2 (ja) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
JP4875490B2 (ja) * 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
EP1660660B1 (en) * 2003-08-15 2013-07-24 ID Biomedical Corporation of Quebec Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20090317420A1 (en) 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (en) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
EP2035035A2 (en) * 2006-06-09 2009-03-18 Novartis AG Immunogenic compositions for streptococcus agalactiae
JP2010508276A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 化膿連鎖球菌のための免疫原性組成物および治療組成物
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
CN104292312A (zh) * 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
US8697085B2 (en) 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
AU2014214613A1 (en) 2013-02-11 2015-08-13 University Of Tennessee Research Foundation Group A streptococcal M-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (en) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
JP4718099B2 (ja) 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原

Also Published As

Publication number Publication date
EP1297145A2 (en) 2003-04-02
AU7227001A (en) 2002-01-21
EP1297145B1 (en) 2008-10-29
WO2002004495A3 (en) 2002-06-13
US7811585B2 (en) 2010-10-12
US20080038268A1 (en) 2008-02-14
US20030165528A1 (en) 2003-09-04
CA2413576A1 (en) 2002-01-17
DE60136360D1 (de) 2008-12-11
ES2316458T3 (es) 2009-04-16
US7247308B2 (en) 2007-07-24
BR0112497A (pt) 2003-11-25
CA2413576C (en) 2012-11-13
WO2002004495A2 (en) 2002-01-17
JP2004502446A (ja) 2004-01-29
JP4718099B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
BE2021C506I2 (cg-RX-API-DMAC7.html)
DE60136360D1 (de) Antigen aus streptococcus pyogenes
ATE542829T1 (de) Impfstoff
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2004030608A3 (en) Nanoemulsion vaccines
AU2001278003A1 (en) Bacteriophage having multiple host range
NO20024246L (no) Endret stamme av det modifiserte vacciniaviruset (Ankara MVA)
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MY125202A (en) Vaccine
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
ATE426026T1 (de) Chimare arterivirus-ahnliche partikel
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
AP2002002685A0 (en) Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
AP2003002734A0 (en) Purification of HBV antigens for use in vaccines.
ATE392216T1 (de) Mycobakterieller impfstoff
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
EP1543838A4 (en) Vaccine against infectious CAT PERITONITIS
SG147465A1 (en) Vaccine
ATE452191T1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties